Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial

Few trials have examined rates of hypersensitivity reactions (HSRs) with intravenous iron formulations used to treat iron deficiency anemia (IDA). This randomized, multicenter, double‐blind clinical trial compared the safety, and efficacy of ferumoxytol versus ferric carboxymaltose (FCM), focusing o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Hematol
Glavni autori: Adkinson, N. Franklin, Strauss, William E., Macdougall, Iain C., Bernard, Kristine E., Auerbach, Michael, Kaper, Robert F., Chertow, Glenn M., Krop, Julie S.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947731/
https://ncbi.nlm.nih.gov/pubmed/29417614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25060
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items